Muscle Mass Is the New Health Metric. Here's Why the Fitness Industry Needs to Pay Attention.
This blog explores how skeletal muscle mass is becoming the key indicator of long-term health, shifting focus beyond weight and body fat. It highlights new science linking muscle to metabolism, ageing, and disease prevention, and the importance of tracking it during weight loss and GLP-1 use. The Evolt 360 makes accessible body composition and muscle tracking simple, helping drive more informed decisions and better long-term health outcomes.

For years, the fitness industry has been obsessed with one number, body fat percentage. Step on a scale, check your BMI, track your kilos. But here's the problem, none of those metrics tell you whether you're actually healthy. Or whether you're going to live a long, high-quality life.
There's a more powerful number hiding in plain sight. And the science, the longevity community, and a growing wave of clinicians are all pointing to the same conclusion.
Skeletal muscle mass is the single most important biomarker of long-term health — and it's time the health and fitness industry started treating it that way.
This isn't a trend driven by bodybuilders or elite athletes. It's a paradigm shift backed by peer-reviewed science, championed by longevity researchers, and now reaching everyday people who are finally asking better questions about their health.
The Quantified Self - COVID Changed How We Think About Our Health
Something shifted profoundly during and after COVID-19. For the first time in modern history, millions of people were forced to confront a simple but uncomfortable truth, the health system can't always save you. Prevention, personalisation, and personal accountability suddenly became urgent, not aspirational.
This gave rise to what researchers and technologists call the Quantified Self, the idea that individuals must take ownership of their own health data. Wearables, continuous glucose monitors, sleep trackers, and body composition scanners moved from niche to mainstream. People stopped waiting to be told they were sick. They started asking, what does my body actually look like on the inside, and what can I do now to protect my future?
The wellness industry has responded, and the question at the centre of the most meaningful conversations is no longer "how much do you weigh?" It's "how much functional, metabolically active muscle are you carrying?"
The quantified self movement has permanently elevated the expectations of health consumers. They want data. They want baselines. They want to track meaningful change over time, not just step on a scale. Interestingly, Evolt executives were talking about the “the quantified self” over ten years ago!
The Pioneers - Dr. Gabrielle Lyon and the Muscle-Centric Medicine Movement
No one has done more to bring the muscle mass conversation into the mainstream than Dr. Gabrielle Lyon, founder of the Institute for Muscle-Centric Medicine and author of Forever Strong. Her central thesis is both simple and revolutionary: the problem with modern chronic disease is not that we have too much fat, it's that we don't have enough muscle.
Dr. Lyon's work has educated millions of people, clinicians and consumers alike, on why skeletal muscle is the cornerstone of metabolic health, hormonal regulation, immune function, and longevity. She argues compellingly that medicine has spent decades focused on reducing what the body has too much of, adiposity, while largely ignoring what it doesn't have enough of, skeletal muscle mass.
Alongside Dr. Lyon, researchers like Dr. Peter Attia, Dr. Stacy Sims, and Professor Stuart Phillips have built a growing body of work positioning muscle as the organ of longevity. Their collective influence is reshaping how doctors, dietitians, personal trainers, and health coaches frame the goal of physical health.
"Muscle is the organ of longevity." — Dr. Gabrielle Lyon
This is no longer fringe thinking. It is becoming the dominant framework for evidence-based preventive health, and the fitness industry has both the opportunity and the obligation to lead its implementation.
Muscle Is Not Just About Aesthetics — It's Your Body's Life Support System
Let's reframe this completely. Skeletal muscle makes up approximately 40% of your total body weight. Most people think of it purely in terms of strength or appearance. But the latest research reveals something far more significant, muscle is a dynamic endocrine organ, meaning it communicates with virtually every other system in your body.
A landmark review published in October 2025 in BioChem, titled "Muscle Mechanics in Metabolic Health and Longevity: The Biochemistry of Training Adaptations," lays this out in comprehensive detail. The authors describe how skeletal muscle's secretome, particularly bioactive proteins called myokines, acts as a central hub coordinating metabolic health, inflammation control, immune function, and tissue adaptation throughout the body.
In plain terms, when your muscles contract, they release signalling molecules that travel to your liver, pancreas, fat tissue, bones, cardiovascular system, and brain. Muscle isn't just moving your body, it's actively protecting it.
The Myokine Revolution
Among the most significant findings from this 2025 review is the role of specific myokines including IL-6, irisin, SPARC, FGF21, and BAIBA. These molecules mediate cross-organ communication that regulates:
• Glucose uptake and insulin sensitivity
• Fat oxidation and lipid metabolism
• Chronic inflammation
• Mitochondrial function and cellular energy
• Neuroplasticity and cognitive health
This is not theoretical. This is the biochemistry happening inside you every time you exercise, and, critically, the biochemistry that diminishes every time your muscle mass declines.
The Statistics Are Striking — and They Should Alarm Us
The condition of progressive muscle loss is called sarcopenia, and its prevalence is far more widespread than most people realise.
5 – 13%
of adults aged 60–70 have clinically significant sarcopenia
11 – 50%
of adults over 80 are affected — up to half the population
No FDA-approved drug
currently exists for sarcopenia — exercise and protein remain the only proven interventions
But sarcopenia isn't just a problem for older adults. Adults begin losing muscle mass from their 30s. Without deliberate intervention, resistance training, adequate protein, and objective measurement, the decline is silent and cumulative.
Research published in the American Journal of Medicine established that muscle mass index is independently associated with all-cause mortality risk in older adults. Not BMI. Not weight. Muscle mass.
And a 2024 prospective cohort study spanning 28 countries confirmed that muscle strength, a direct correlate of skeletal muscle mass, is significantly associated with survival across the oldest age groups studied.
The science is unequivocal: more muscle mass means lower mortality risk, better metabolic health, and a higher quality of life as you age.
Muscle Mass and Metabolic Health - The Connection We Can't Ignore
One of the most compelling reasons to track skeletal muscle mass, particularly in today's environment of rising type 2 diabetes, insulin resistance, and metabolic dysfunction, is muscle's role as the body's primary glucose disposal site.
A 2025 systematic review published in Acta Diabetologica confirmed what the science has been pointing to for years: skeletal muscle is the largest insulin-sensitive tissue in the human body, and reductions in muscle mass and strength substantially impact glucose metabolism and increase type 2 diabetes risk.
Here's why this matters for the fitness industry. When someone engages in resistance training and builds skeletal muscle mass, they are not just changing how they look. They are:
- Increasing the volume of insulin-sensitive tissue available to clear glucose from the bloodstream
- Upregulating glucose transporters (GLUT4) in muscle cells
- Reducing the metabolic load on the pancreas
- Lowering systemic inflammation through myokine release
- Improving cardiovascular risk markers
This is the case for why muscle mass is not a vanity metric. It is a clinical health metric, and it deserves to be measured, tracked, and optimised accordingly.
Muscle and the Brain - A Connection Longevity Science Is Just Beginning to Understand
Perhaps the most surprising finding emerging from the 2025 BioChem review, and from a growing body of research, is the profound link between skeletal muscle mass and brain health.
Muscle-derived myokines cross the blood-brain barrier and directly influence neurogenesis, neuroplasticity, and neuroprotection. Research published in Frontiers in Aging Neuroscience identified that exercise-induced myokines mediate a muscle-brain endocrine loop, with implications for cognitive decline, mood disorders, and even neurodegenerative conditions such as Alzheimer's disease.
A 2025 review in Nature Reviews Endocrinology specifically addressed the therapeutic potential of myokines for brain ageing and neurodegeneration. The muscle-bone-brain axis is becoming one of the most significant areas of longevity research.
Building and maintaining muscle mass doesn't just protect your body, it protects your mind. For anyone invested in healthy ageing, cognitive longevity, or the prevention of neurodegenerative disease, skeletal muscle mass tracking is not optional. It is essential.
GLP-1 Medications and Peptide Therapies - Why Muscle Tracking Is Now a Clinical Imperative
The explosion of GLP-1 receptor agonists, semaglutide, tirzepatide, and the next generation of weight loss medications, has introduced one of the most important clinical challenges in modern metabolic health: the risk of losing muscle mass during rapid weight reduction.
Clinical trials and real-world data have confirmed that significant proportions of weight lost on GLP-1 medications can come from lean muscle mass, not just fat. For patients already carrying insufficient muscle, this is not a neutral outcome. It is a compounding health risk, accelerating the trajectory toward sarcopenia, metabolic fragility, and reduced functional capacity.
The same applies to the growing use of peptide therapies in longevity and wellness medicine, CJC-1295, BPC-157, TB-500, and others, which are being used in conjunction with body recomposition goals. The question every prescribing clinician and wellness practitioner should be asking is: what is this protocol doing to the patient's skeletal muscle mass?
Baselining and tracking skeletal muscle mass should be a non-negotiable component of every GLP-1 and peptide therapy protocol.
Without a baseline scan before treatment and regular tracking throughout, clinicians are navigating one of the most consequential body composition changes their patients will experience, completely blind.
This creates a significant opportunity for fitness facilities, wellness clinics, allied health providers, and medical weight loss centres to position body composition scanning as a clinical standard of care, not an optional add-on.
The Evolt 360 Body Composition Analyzer is uniquely positioned to serve this need. Non-invasive, fast, and deployable outside of clinical settings, it can provide the longitudinal muscle mass data that treatment decisions should be built on.
The Fitness Industry's Moment - From Body Composition to Health Transformation
The fitness industry has always been good at changing how people look. What it hasn't always communicated is the deeper transformation that resistance training and body composition improvement deliver, a measurable, clinically significant improvement in long-term health.
That gap is closing. And the most progressive gyms, personal trainers, group fitness operators, and wellness businesses are already making the shift, elevating their services from aesthetic outcomes to health outcomes.
This is more than a positioning exercise. It's a reflection of what clients actually want in a post-COVID world. The consumer who came in wanting to lose 5 kilos is now asking about their metabolic health, their inflammation markers, their risk of diabetes. They've done the reading. They've listened to the podcasts. They know muscle mass matters.
The fitness industry's response needs to match that sophistication. Offering body composition scanning, setting skeletal muscle mass baselines, programming specifically around muscle preservation and hypertrophy, and celebrating muscle gains as the primary success metric, these are the service upgrades that differentiate a modern health business from a commodity gym.
Making a difference to body composition is meaningful. Improving long-term health is an entirely greater movement, and the fitness industry is uniquely positioned to lead it.
The Wellness Industry Is Shifting — Muscle Mass Is the New Trending Metric
Over the last two to three years, I've watched a meaningful shift occur in the health and fitness landscape. The conversation has moved, from weight and body fat to body composition quality. And at the centre of that conversation is skeletal muscle mass.
This shift is being driven by several converging forces -
- The rise of the longevity movement, with researchers like Peter Attia and Dr. Gabrielle Lyon reframing muscle as the organ of longevity
- The explosion of GLP-1 medications and peptide therapies, driving urgent clinical conversation about muscle preservation during treatment
- The quantified self movement, with consumers demanding objective health data, baselines, and trackable outcomes
- Growing consumer awareness around metabolic health, insulin sensitivity, and the limitations of BMI as a standalone measure
- The increasing adoption of body composition technology in gyms, clinics, spas, and corporate wellness programs
Body fat percentage had its moment. It was a step in the right direction, but it's incomplete. You can have a healthy body fat percentage while being critically deficient in skeletal muscle mass. The metric that more accurately predicts long-term health outcomes, disease risk, and quality of life is skeletal muscle mass.
The fitness industry's job is to shift the goalposts, from weight loss to body composition optimisation, and from body composition to muscle mass as the lead biomarker of health.
Measurement Is the Foundation — and the Evolt 360 Is Built for This Moment
Here's the challenge, you cannot improve what you cannot measure. And until recently, measuring skeletal muscle mass accurately required access to DXA scanning, expensive, clinic-based equipment not available in most gyms, spas, or wellness centres.
That's where the Evolt 360 Body Composition Analyzer changes everything.
The Evolt 360 uses medical-grade bioelectrical impedance analysis (BIA) to deliver a comprehensive body composition scan in under 60 seconds. What makes the Evolt 360 stand apart is its focus on outcome-driven results. It doesn't just tell you what you're made of, it generates personalised daily calorie and macronutrient targets based on body composition, goal, training type, and training intensity. That individualisation is what connects the data directly to action, and to the role that resistance training plays in building and maintaining skeletal muscle mass. That's where fitness professionals shine.
Now operating across 54 countries, the Evolt 360 is trusted by gyms, allied health clinics, sports performance facilities, medical weight loss centres, and luxury spa environments. It provides the objective baseline that every health conversation should start from, and the tracking data that makes progress meaningful.
Why Baseline and Tracking Matter
A single scan is informative. A series of scans over time is transformative.
When clients or patients can see their skeletal muscle mass trend upward in response to a training program or nutritional intervention, the behaviour change that follows is profound. Abstract goals like "get healthier" become concrete: "I've increased my skeletal muscle mass by 2.5 lbs in 12 weeks." That is a measurable, meaningful health outcome.
For fitness professionals, this reframes the entire value proposition. You are no longer selling weight loss. You are delivering a clinically significant health improvement, documented, tracked, and evidence-backed.
For GLP-1 and peptide therapy providers, it means your patients are protected. You know their muscle baseline before treatment begins, and you can intervene with precision if muscle preservation becomes a concern during the protocol.
For clinicians, allied health professionals, and wellness operators: offering skeletal muscle mass scanning positions your service at the frontier of evidence-based health — exactly where your clients are heading.
The Industry's Opportunity — and Obligation
The research is clear. The consumer trend is accelerating. The clinical need is urgent. The tools exist. The only thing left is for the fitness and wellness industry to embrace skeletal muscle mass as the lead health metric, and build programs, conversations, and client outcomes around it.
Whether you're a personal trainer, a gym owner, a physiotherapist, a spa director, a GLP-1 prescriber, or a corporate wellness lead, the question to ask your clients is no longer:
• "What does the scale say?"
The question is:
• "What does your muscle say?"
Because according to the latest science, and the most forward-thinking practitioners in health and fitness, your muscle is saying everything worth knowing about your long-term health.
Research References
Primary citation: "Muscle Mechanics in Metabolic Health and Longevity: The Biochemistry of Training Adaptations" — BioChem, MDPI, October 2025. https://www.mdpi.com/2673-6411/5/4/37
Supporting studies: Andersen et al. (2024), Journal of Cachexia, Sarcopenia and Muscle (28-country cohort); Putranata et al. (2025), Acta Diabetologica (systematic review, T2DM and muscle mass); Krauss et al. (2014), American Journal of Medicine (muscle mass index and longevity); Rai & Demontis (2026), Nature Reviews Endocrinology (myokines and neurodegeneration). Dr. Gabrielle Lyon, Forever Strong (2023), Institute for Muscle-Centric Medicine.
Guest Author, Kylie Bruno, Product Manager | Evolt




